Andrew Fein's
Stock Forecasts
12.5%
3/24 win trades
Price targets by Andrew Fein
| Company name & ticker | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|
 United Therapeutics Corporation UTHR | 11 months ago | $425 35.68% upside | $361.4 | StreetInsider | Previous targets (0) |
 Amylyx Pharmaceuticals, Inc. AMLX | 11 months ago | $8 2.04% upside | $3.92 | StreetInsider | Previous targets (0) |
 Sutro Biopharma, Inc. STRO | 12 months ago | $12 1293.72% upside | $3.61 | StreetInsider | Previous targets (0) |
 KalVista Pharmaceuticals, Inc. KALV | about 1 year ago | $20 56.12% upside | $12.87 | StreetInsider | Previous targets (0) |
 Kymera Therapeutics, Inc. KYMR | about 1 year ago | $60 40.94% upside | $40.31 | StreetInsider | |
 Vertex Pharmaceuticals Incorporated VRTX | about 1 year ago | $600 53.64% upside | $505.78 | TheFly | |
 Savara Inc. SVRA | about 1 year ago | $10 237.83% upside | $3.84 | TheFly | Previous targets (0) |
 Syros Pharmaceuticals, Inc. SYRS | over 1 year ago | $15 272627.27% upside | $5.7 | StreetInsider | Previous targets (0) |
 Merus N.V. MRUS | over 1 year ago | $85 32.33% upside | $54.87 | StreetInsider | Previous targets (0) |
 Insmed Incorporated INSM | over 1 year ago | $70 -45.06% downside | $48.06 | StreetInsider | Previous targets (0) |
 Dyne Therapeutics, Inc. DYN | over 1 year ago | $48 291.83% upside | $33.83 | StreetInsider | Previous targets (0) |
 ACADIA Pharmaceuticals Inc. ACAD | over 1 year ago | $27 8.12% upside | $17.13 | TheFly | Previous targets (0) |
 Blueprint Medicines Corporation BPMC | over 1 year ago | $135 4.27% upside | $107 | TheFly | Previous targets (0) |
 Neurocrine Biosciences, Inc. NBIX | over 1 year ago | $160 20.47% upside | $143.03 | StreetInsider | Previous targets (0) |
 Biogen Inc. BIIB | over 1 year ago | $300 116.21% upside | $201.99 | StreetInsider | Previous targets (0) |
 Arvinas, Inc. ARVN | over 1 year ago | $87 1118.48% upside | $37.26 | StreetInsider | Previous targets (0) |
Other analysts covering same stocks
Geoff Porges
Leerink Partners
100%
win rate
Andrew Galler
Wolfe Research
100%
win rate
Olivia Brayer
Cantor Fitzgerald
60%
win rate
Steve Chesney
Atlantic Equities
60%
win rate
Mark Breidenbach
Oppenheimer
50%
win rate
Charles Duncan
Cantor Fitzgerald
40%
win rate